ASHP to Testify at House Hearing on Compounding

Published Online: Tuesday, July 16, 2013
Follow Pharmacy_Times:
PRESS RELEASE

July 16, 2013--ASHP is scheduled to testify today at a congressional hearing on reforming the regulatory framework of pharmacy compounding.
 
Kasey K. Thompson, Pharm.D.,  M.S., ASHP vice president of policy, planning, and communications, will represent the Society at the hearing called by the Health Subcommittee of the House Energy and Commerce Committee.
 
ASHP members are encouraged to email their House of Representatives member and ask for support of compounding legislation that establishes a clear jurisdictional boundary between the FDA and state boards of pharmacy.
 
The hearing will be broadcast at 3:00 p.m. on the Committee's website.
Related Articles
John Moorman, PharmD, BCPS, Pharmacist at Akron General Medical Center in Ohio discusses other valuable information about transitions of care programs.
John Moorman, PharmD, BCPS, Pharmacist at Akron General Medical Center in Ohio discusses the transition of care pilot program at Akron General.
John Moorman, PharmD, BCPS, Pharmacist at Akron General Medical Center in Ohio discusses the Provider Status Movement in Ohio.
John Moorman, PharmD, BCPS, Pharmacist at Akron General Medical Center in Ohio talks about the outcome metrics of care transitions that pharmacists should pay attention to.
Latest Issues
$auto_registration$